Quercetin is a flavonoid abundantly present in vegetables and fruits and known to possess therapeutic potentials for the prevention and treatment of different diseases owing to its anti-oxidant, anti-inflammatory, anti-viral, and anticancer activities. 1,2 However, the oral bioavailability of quercetin has been reported to be less than 1% in human because of its low aqueous solubility. 3,4 Nevertheless, based on our neutraceutical market search, numerous commercial products of quercetin have been generally formulated as conventional dosage forms such as tablets and capsules that are not specially designed for enhancing the aqueous solubility and dissolution behavior of quercetin.Various nano-sized pharmaceutical formulations have been investigated to improve the aqueous solubility and dissolution behavior of quercetin, such as liposomes, 5 polymeric micelles, 6 and solid lipid nanoparticles. 7 Among them, liposomes are particularly promising because they can efficiently entrap quercetin in the hydrophobic domain of the lipid bilayer, thereby solubilizing the drug and stabilizing its anti-oxidative activity, which could be easily lost in an aqueous environment. 8 However, liposomes suspended in water may aggregate, fuse each other, and leak the entrapped drug as time progresses due to the dispersion instability of liposomes and the fluidic nature of the lipid bilayer. The physically instable properties of liposomes can lead to significant changes in the in vivo biodistribution, efficacy, and safety of drugs incorporated in liposomes. 9,10 To enhance the physical stability of liposomes, freezedried liposomes have been explored because the undesirable phenomena such as drug leakage, aggregation, and fusion among the liposomes are facilitated in an aqueous environment. Owing to their dried state, the physical stability of freeze-dried liposomes can be maintained substantially longer than liposomes suspended in water. However, liposomes can be physically damaged by ice crystals and aggregated during the freeze-drying procedure, resulting in considerable changes in the membrane structure, particle size, and particle size distribution of liposomes. 11 To stabilize liposomes during lyophilization, diverse lyoprotectants have been exploited. In particular, saccharides have been widely used as lyoprotectants because they can form an amorphous glassy matrix with a high viscosity under a freezing condition and thereby prevent the formation of ice crystals, aggregation, and fusion of liposomes. 12 Thus, in this study we aimed to enhance the physical stability of freeze-dried liposomes loaded with quercetin using four different saccharides such as glucose, lactose, sucrose, and trehalose. The lyoprotectants were selected based on their different glass transition temperatures, 13 which is known to be crucial for the lyoprotective ability. 14 We evaluated the effect of the addition of the saccharides to the liposomal suspension containing quercetin on the physical stability of the liposomes after the freeze-drying and rehydratio...